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Community treatment orders (CTOs) have been available in
Scotland since 2005 and in England and Wales since 2008.
The provision of powers to compel in the community was
controversial within the healthcare and legal professions,
among those who use services and among organisations
working on their behalf. Indeed, an alliance was formed in
2008 in England and Wales of 32 different organisations
from all these stakeholder groups to express concern
regarding the proposed introduction.1 In Scotland a CTO
can be commenced in the community, whereas in England
and Wales it can only be made when a patient is discharged
from involuntary treatment in hospital. The most common
discretionary conditions written into the orders are to take
medication and to see clinical team members, although
powers are potentially wider.
In England and Wales the CTO is initiated by the
clinician. This is entirely discretionary and there are no
situations in which one must be used. In Scotland the
decision to grant a CTO rests with the mental health
tribunal, on the advice of clinicians and mental health
ofﬁcers. This allows considerable scope for variation in
practice. Defferent factors inﬂuencing the variable use of
CTOs have been proposed by Dawson,2 including:
. the legal structure of the CTO regime
. the community mental health services available
. the clinician’s and practitioner’s views about the possible
impact of coercion on their relationships with patients
. the expectations of third parties.
Attitudes of psychiatrists in England and Wales were
surveyed by Crawford et al3 in 2000, when 45% of the 1171
respondents were in favour of a system allowing CTOs. In our
survey of psychiatrists in England and Wales shortly after the
introduction of CTOs this proportion had risen to 60%.4
Since their introduction in England and Wales, CTOs
have been used extensively. The Care Quality Commission
reported that 18 942 CTOs had been used in England and
Wales by 31 March 2013 and on that date 5218 patients were
on a CTO.5 The overall number of patients subject to a CTO
shows a year on year increase of 10%.5 The only randomised
controlled study of the effectiveness of CTOs1 included
333 participants and demonstrated no difference between
those subject to a CTO and those not over a 12-month
period across a wide range of outcomes. The study has
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Aims and method Community treatment orders (CTOs) are increasingly embedded
into UK practice and their use continues to rise. However, they remain highly
controversial. We surveyed psychiatrists to establish their experiences and current
opinions of using CTOs and to compare ﬁndings with our previous survey conducted
in 2010.
Results The opinions of psychiatrists in the UK have not changed since 2010 in spite
of recent evidence questioning the effectiveness of CTOs. Clinical factors (the need
for engagement and treatment adherence, and the achievement of adherence and
improved insight) remain the most important considerations in initiating and
discharging a CTO.
Clinical implications Given the accumulating evidence from research and clinical
practice that CTOs do not improve outcomes, it is concerning that psychiatrists’
opinions have not altered in response, particularly given the implications for patient
care.
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proved to be controversial and engendered a number of
critical commentaries.6
In Scotland, where CTOs have been available for longer,
their use has also increased, to the extent that in 2013-2014
they accounted for 41% of the total number of compulsory
treatment orders, reﬂecting a signiﬁcant drop in the number of
hospital-based orders (the remaining 59% of all compulsory
treatment orders) and consequently, a continued shift to the
community for people subject to compulsion.7 Given these
trends, we decided to compare and contrast the views of
psychiatrists north and south of the border.
Study design
We conducted a national survey using an adapted version of
the instrument developed by Manning et al,4 which in turn
was based on a survey of clinicians inNewZealand conducted
10 years after CTOs were introduced there.8 We aimed to
determine psychiatrists’ views regarding CTOs now and to
assess any changes over time and differences across context.
Method
Sample
The link to the survey was sent by email (from the Royal
College of Psychiatrists) to all consultant psychiatrists listed
as members of the General Adult Psychiatry and the
Rehabilitation and Social Psychiatry Faculties at the
beginning of June 2014. A reminder was sent after
3 weeks. No responses were accepted after 8 weeks. To
avoid any duplications only one response from any one IP
address would be accepted.
Survey instrument
We made minimal alterations to Manning’s questionnaire to
maximise comparability with that survey and with the
earlier New Zealand study.8 The survey included questions
asking the respondents to rate the importance of a range of
factors inﬂuencing CTO practice or statements about CTOs
using ﬁve-point Likert scales (from 1, very important/
strongly agree to 5, not important at all/strongly disagree).
Respondents were also asked about sociodemographic
information and the number of CTOs they had applied for.
Statistical analysis was carried out using SPSS version
17 for Windows. A descriptive analysis was carried out with
data presented as appropriate for the distribution (mean and
standard deviation for normally distributed data, median
and interquartile range for non-normally distributed data,
and number and proportion for categorical data).
Results
Of the 3534 psychiatrists emailed, 364 responses were
received. The response rate (10.3%) is lower than that of the
original survey (37%) and the New Zealand survey (44%),
both of which used hard copy questionnaires and not
electronic ones. Where appropriate, we compare our results
with our ﬁrst survey from 2010 and the New Zealand study.
The majority of the respondents (n=327) were based in
England and Wales and 37 were from Scotland. These
numbers approximately reﬂect the differing populations of
the countries concerned. The ethnicity and gender of
respondents did not differ signiﬁcantly from the overall
membership of the Royal College of Psychiatrists.9,10 Most
(85%) had been working in psychiatry for longer than 10 years.
The mean number of CTOs applied for was 15, with a
reported range from 0 to 100. There was signiﬁcant
variation between posts in terms of the use of CTOs in
routine practice, with understandably marked differences
between, for example, in-patient and community services. The
overwhelming majority of respondents (86%) reported that
none of their applications for CTOs had been turned down.
Many respondents added written comments, suggesting
high levels of interest in the topic, as also reported in our
previous survey.
CTO impact on the therapeutic relationship
When asked about the therapeutic relationship, 24% of
respondents in England and Wales believed that CTOs help
the relationship, 10% that they hinder it and 56% that they
both help and hinder it. In Scotland the ﬁgures were 18%,
0% and 76% respectively.
Important factors in the decision to use a CTO
The survey presented 11 factors and asked the respondent to
rate their relative importance when deciding to use a CTO.
The most important factor for responders in England and
Wales was ‘To ensure contact with mental health profes-
sionals’, and ‘Promoting compliance with medication’ was
ranked second. The ﬁve reasons deemed most important
were the same in all four surveys over time and location.
These results are summarised in Table 1.
Thirty-four respondents added additional reasons such
as ‘to make the patient feel more secure’, ‘to establish
insight’ or ‘to gradually promote a sense of independence’.
Important factors in the decision to discharge
a patient from a CTO
Development of insight and adherence to treatment were
rated as the most important factors in discharging patients
from CTOs. The mean ratings suggest that these were
considered very important. Again, the ﬁve most important
factors were the same in all four surveys. These results are
summarised in Table 2.
Mechanisms inﬂuencing how CTOs work
Respondents were presented with nine possible mechan-
isms by which CTOs may affect outcome. The three
mechanisms deemed most important were ensuring medi-
cation adherence, ensuring a greater period of stability, and
signalling to the patient that they have severe mental
illness. In Scotland the ﬁrst two were endorsed but the third
most inﬂuential factor was the binding of services to the
patient, with ‘signalling’ being just behind in fourth
position. These results are summarised in Table 3.
The importance of factors that may undermine
the effectiveness of CTOs
The results here are the same as our earlier survey, with
substance misuse (mean rating 1.92), lack of adequate
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supported accommodation (mean rating 2.23), and failure to
enforce adherence (mean rating 2.31) being seen as most
important. The ranking of factors was the same in both
England and Wales surveys and in the Scottish 2014 sample.
Factors important in the introduction of CTOs
The rank order of perceived signiﬁcance of factors behind
the introduction of CTOs as listed in this survey was as
follows for respondents in England and Wales (a rating of 1
indicates strong agreement, 3 indicates a neutral stance and
5 strong disagreement; mean ratings are given in brackets:
the lower the mean rating, the higher the factor
signiﬁcance):
1 to enforce better community services and follow-up
for those most at risk (2.22)
2 as a response to public pressure (in respect to acts of
violence committed by mentally ill patients) (2.45)
3 as a result of procedural evolution - moving from
Sections 17 and 25 (of the Mental Health Act 1983)
to more explicit framework for treating those with
mental illness in the community (2.51)
4 to reduce pressure on acute psychiatric beds (2.89)
5 to reduce coercion by reducing length of stay in
psychiatric hospitals (2.95)
6 as a result of international research evidence (3.53).
There is no difference in the listed ranking from our ﬁrst
survey.4 The results for Scottish respondents are different in
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Table 1 The mean rating (and listed rank) of importance attached by psychiatrists to key factors in decision to use









To ensure contact with mental health professionals 1.25 (2) 1.7 (1) 1.86 (3) 1.79 (1)
To promote adherence to medication 1.19 (1) 1.71 (2) 1.78 (1) 2.03 (4)
To protect from consequence of relapse 1.47 (4) 1.74 (3) 1.83 (2) 2.08 (5)
To ensure rapid detection of relapse 1.84 (5) 2.10 (4) 2.24 (5) 1.90 (3)
To provide the authority to treat the patient 1.31 (3) 2.27 (5) 2.08 (4) 1,81 (2)
To facilitate readmission to in-patient care 2.75 (10) 2.41 (6) 2.56 (6) 2.43 (7)
To reduce the risk of violence to others 2.56 (6) 2.42 (7) 2.61 (7) 2.68 (8)
To provide greater security for patients’ families and caregivers 2.56 (6) 2.56 (8) 2.70 (8) 2.41 (6)
To reduce the risk of self-harm by the patient 2.56 (6) 2.6 (9) 2.81 (9) 2.74 (9)
To enhance the obligation of service providers to the patient 2.63 (9) 2.97 (10) 3.12 (10) 2.97 (10)
To help ensure police assistance with patients will be available 4.03 (11) 3.72 (11) 3.74 (11) 3.31 (11)
a. Rating: 1, very important; 3, neutral; 5, not important.
b. 10 years post-introduction.










Development of insight 1.17 (1) 1.53 (1) 1.61 (1) 1.56 (2)
Adherence to treatment 1.17 (1) 1.60 (2) 1.61 (1) 1.53 (1)
Clinical improvement 1.33 (3) 1.60 (2) 1.61 (1) 1.58 (3)
Reduced risk to others 1.83 (4) 1.88 (4) 2.04 (4) 1.84 (4)
Reduced risk to self 1.97 (5) 1.98 (5) 2.12 (5) 1.87 (5)
Suitable accommodation and community supervision 2.07 (6) 2.05 (6) 2.18 (6) 2.12 (6)
Reduced substance use 2.07 (6) 2.06 (7) 2.31 (7) 2.25 (7)
Improved lifestyle 2.33 (8) 2.12 (8) 2.41 (8) 2.65 (11)
To increase the patient’s freedom 2.60 (11) 2.29 (9) 2.53 (10) 2.84 (12)
Employment 2.67 (12) 2.37 (10) 2.41 (8) 2.60 (9)
Improved family relationships 2.33 (8) 2.41 (11) 2.64 (11) 2.32 (8)
Enhanced social/cultural networks 2.47 (10) 2.47 (12) 2.71 (12) 2.64 (10)
The patient’s desire to be discharged 2.93 (13) 2.49 (13) 2.81 (13) 3.09 (14)
Suitable recreational activities (including exercise) 2.93 (13) 2.80 (14) 3.14 (14) 3.02 (13)
Enhanced cultural identity 3.47 (15) 2.97 (15) 3.42 (15) 3.19 (15)
a. Rating: 1, very important; 3, neutral; 5, not important.
b. 10 years post-introduction.
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that the ‘public pressure’ factor is rated of less importance
(3.31).
Support for the introduction and use of CTOs
We asked clinicians to rate their level of agreement with
several statements regarding CTOs (mean ratings are given
in brackets):
1 ‘CTOs complement existing legislation to provide a
greater choice of treatment options’ (2.37)
2 ‘The increase in compulsory powers is appropriate
for the potential clinical and social beneﬁts’ (2.40)
3 ‘I supported the introduction of CTOs’ (2.55)
4 ‘There is sufﬁcient clinical guidance to feel conﬁdent
placing patients on CTO’ (2.60)
5 ‘I can already see the beneﬁts of the use of CTOs’
(2.63).
Those statements with a mean of over 3, suggesting
disagreement, were:
1 ‘The introduction of CTOs will have no long-term
beneﬁt’ (3.17)
2 ‘Well-resourced community services can provide the
same beneﬁts without using compulsory powers’
(3.22)
3 ‘There is insufﬁcient clinical evidence to feel
comfortable placing patients on CTO’ (3.46)
4 ‘The introduction of CTOs was a retrograde step for
mental health services’ (3.59).
Factors discouraging clinicians from using CTOs
Mean scores here tended to cluster around the mid-range,
suggesting less clearly held beliefs and opinions than in
other areas of the survey. The most important discouraging
factors were considered to be concern for civil liberties
(mean rating 2.29), administrative burden (mean rating
2.31), and the degree of coercion involved (mean rating
2.41). Lack of evidence to support effectiveness was ranked
fourth most important (mean rating 2.51). No other factors
had mean ratings below 3 (a level that suggests general
agreement). Comparing the four surveys across time and
geography, there are again remarkably few differences.
Should Section 17 or CTOs be used in community care?
Respondents in England and Wales were asked to compare
the use of CTO and Section 17 leave from hospital: 58%
believed that CTOs were a more appropriate way of treating
patients in the community than the medium- to long-term
use of Section 17 leave and the majority believed they were
less coercive (48% v. 23%). There was widespread belief
(expressed by 61% of respondents) that in clinical care there
was a signiﬁcant difference in powers between Section 17
leave and CTOs.
Contrasts between jurisdictions
There was some variation in opinions expressed on CTOs
incorporating medical treatment that is ‘likely to prevent a
disorder worsening or likely to alleviate the symptoms or
effects of the disorder’: 47% of respondents from England
and Wales and 68% of Scottish respondents agreed. Further,
84% of Scottish respondents agreed that it should be
possible to place a patient not currently under detention on
a CTO, but only 36% of respondents in England and Wales
did so. There were also differences between jurisdictions
regarding signiﬁcantly impaired decision-making ability
(SIDMA) as a criterion for CTO use: 80% of psychiatrists
in Scotland and 28% of those in England and Wales
accepted it. This is a criterion in the Scottish legislation
(Mental Health (Care and Treatment) (Scotland) Act 2003)
but not in England and Wales (Mental Health Act 1983).
Even though the number of respondents from Scotland was
relatively small at 37, and we did not believe as a result that
detailed analysis was appropriate, important differences do
appear to be present in attitudes and beliefs.
Discussion
The results of this survey are strikingly similar overall to the
previous survey in England and Wales conducted when
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Ensures medication adherence for a lengthy period during which
other changes can occur
1.3 (1) 1.90 (1) 1.95 (1)
Ensures a greater period of stability 1.57 (2) 2.12 (2) 2.26 (2)
Signals to patient that they have a SMI which needs active
management
2.40 (4) 2.27 (3) 2.28 (3)
Commits service providers to the patient 2.40 (4) 2.66 (4) 2.76 (4)
Gives others the conﬁdence to care for the patient 2.63 (7) 2.75 (5) 2.79 (5)
Binds community mental health services into place 2.37 (3) 2.80 (6) 2.89 (6)
Mobilises social support for the patient 2.60 (6) 2.97 (7) 3.25 (8)
The patient gives up key conﬂict areas to external agents 3.07 (8) 3.07 (8) 3.30 (9)
Encourages the patient to take responsibility 3.30 (9) 3.08 (9) 3.15 (7)
SMI, serious mental illness.
a. Rating: 1, very important; 3, neutral; 5, not important.
122
these powers were relatively new in those countries.
Nearly 6 years on, with no measurable reductions in bed
use or improved outcomes from clinical practice or
research,11-15 the use of CTOs continues to increase.5,6
It is likely that the reasons for this are complex and
relate to factors within both clinicians and the systems they
operate in. In a discretionary system where there is never a
situation where a CTO must be enacted, the opinions and
beliefs of senior clinicians, particularly psychiatrists, are
likely to be inﬂuential. Clinical factors remain by far the
most important in decisions to initiate or discharge a CTO.
These have been the same in all four studies spanning time
and geography.3,4,8,16 The key factors were as follows: to
ensure contact with professionals, to promote medication
adherence, and to identify relapse and protect the individual
from its consequences. Similarly, the factors in deciding
when to discharge a CTO have been remarkably stable:
development of insight, treatment adherence, clinical
improvement and reduced risk to others and self (in that
order).
Clinicians reported feeling discouraged by concerns for
civil liberties and the additional administrative burden when
considering CTOs. Factors believed to undermine CTOs were
substance misuse, lack of supported accommodation and
failure to enforce adherence.
The written comments of a number of respondents
expressed frustration around how the in-patient/out-patient
split complicates practice. A number commented also that a
general pressure on beds may lead to inappropriate use of
CTOs to facilitate early discharge or to make readmission
‘easier’ if needed. Clearly these raise ethical concerns if
compulsory powers are being commonly used as a practical
measure to access services that should be available
regardless of legal status. It has also been reported
anecdotally that clinicians feel pressurised to use CTOs in
case there is a negative outcome such as suicide or
aggression and they are criticised for not having done so.
It seems likely that clinicians across the UK will
continue to use CTOs in large numbers as long as they
remain available. New evidence, both in the form of large-
scale utilisation data and research studies,1,7,17 has not
affected opinion signiﬁcantly. This is of concern in a branch
of medical science that ostensibly embraces evidence-based
practice. It seems crucial therefore that we continue to
evaluate our practice,18 gather good-quality evidence, and
pay attention to it to facilitate greater understanding and
sophistication in the use of compulsion. This will better
serve our patients.
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